Page Lisa A, Rehman Ahmad, Syed Habib, Forcer Kathryn, Campbell Graham
Brighton and Sussex Medical School, Brighton, United Kingdom.
Sussex Partnership National Health Service (NHS) Foundation Trust, Worthing, United Kingdom.
Front Psychiatry. 2021 Nov 26;12:743599. doi: 10.3389/fpsyt.2021.743599. eCollection 2021.
Psychedelic-assisted psychotherapy is a promising approach in psychiatry; evidence is growing and it may not be long before mainstream services are expected to offer it to selected patients. This pilot study examined the attitudes and knowledge of NHS psychiatrists of all levels towards psychedelic-assisted psychotherapy and explored potential barriers and facilitators to its implementation. A mixed-methods approach was adopted, using a cross-sectional survey and focus groups. All psychiatrists in one NHS mental health trust were approached by email to participate. The survey was analysed using a simple descriptive approach and thematic analysis was used for the focus groups. Eighty-three (25.7%) psychiatrists participated in the survey. All psychiatrists were familiar with one or more psychedelic substances. Although 77.2% felt that there should be a role for controlled or therapeutic use of psychedelics, trainees appeared better informed than non-training grade psychiatrists. Psychiatrists of all grades did not feel prepared to participate in the delivery of psychedelic-assisted psychotherapy. Thematic analysis of the focus groups identified three main themes in relation to psychedelic-assisted psychotherapy: "," "," and "." NHS psychiatrists are positive about the potential for psychedelic-assisted therapy to advance psychiatric practise. However, psychiatrists are lacking in confidence or preparedness to implement this treatment should it become a mainstream option and significant training needs were identified. Thematic analysis highlighted the need for societal shifts as well as professional ones.
迷幻剂辅助心理治疗是精神病学中一种很有前景的方法;证据越来越多,预计不久主流服务机构就会为选定的患者提供这种治疗。这项试点研究调查了各级英国国家医疗服务体系(NHS)精神科医生对迷幻剂辅助心理治疗的态度和知识,并探讨了其实施的潜在障碍和促进因素。采用了混合方法,包括横断面调查和焦点小组。通过电子邮件邀请了一家NHS心理健康信托机构的所有精神科医生参与。调查采用简单描述性方法进行分析,焦点小组采用主题分析。83名(25.7%)精神科医生参与了调查。所有精神科医生都熟悉一种或多种迷幻物质。尽管77.2%的人认为迷幻剂的受控或治疗用途应该发挥作用,但实习医生似乎比非实习级别的精神科医生了解得更多。所有级别的精神科医生都觉得没有准备好参与迷幻剂辅助心理治疗的提供。焦点小组的主题分析确定了与迷幻剂辅助心理治疗相关的三个主要主题:“……”、“……”和“……”。NHS精神科医生对迷幻剂辅助治疗推进精神病学实践的潜力持积极态度。然而,如果这种治疗成为主流选择,精神科医生缺乏实施这种治疗的信心或准备,并且确定了重大的培训需求。主题分析强调了社会转变以及专业转变的必要性。